Why Shares of Eldorado Resorts Popped 12% in September

Why Shares of Eldorado Resorts Popped 12% in September
What happened Shares of Eldorado Resorts (NASDAQ: ERI) jumped 11.5% in September, according to data provided by S&P Global Market Intelligence , after the company was upgraded by a rating agency and announced a well-priced debt offering. Since debt fuels the gaming industry, both moves are positive developments for investors. So what The upgrade came from Moody’s, which increased its... Read More

European Equity Benchmarks Close Mixed; Investors Favor Automotive Stocks Over Supermarkets, Banks

European Equity Benchmarks Close Mixed; Investors Favor Automotive Stocks Over Supermarkets, Banks
The broad-based major European indices closed mixed in Wednesday’s trading session, as automakers buoyed the German market, while supermarket operators and banks weighed on the UK and French exchanges. In economic news, Eurostat, the statistical office of the European Union, reported the seasonally adjusted volume of retail trade fell 0.5% in the euro area (EA19) in August, compared with July,... Read More

Midday Update: U.S. Stocks Turn Positive After Tillerson Denies Plans to Resign

Midday Update: U.S. Stocks Turn Positive After Tillerson Denies Plans to Resign
Wall Street’s major market indicators have all flipped into positive territory as a high-ranking administration official dismissed rumors of his resignation, and economic data indicated significant growth in the services sector of the economy. The Dow Jones Industrial Average, S&P 500 and Nasdaq have all set record highs with the S&P extending its winning streak to a seventh straight day.... Read More

Celsion's Immunotherapy Candidate Impresses, Stock Surges

Celsion's Immunotherapy Candidate Impresses, Stock Surges
Celsion Corporation CLSN announced results from phase Ib study – OVATION – evidently showing biological activity of its immunotherapy candidate, GEN1, in advanced ovarian cancer patients. Celsion is developing the candidate for newly diagnosed patients, who will be administered in combination with neoadjuvant chemotherapy. Investors cheered the news as the stock skyrocketed over 300% on Tuesday. In fact, shares of... Read More

PepsiCo Earnings: Beverages Dip, but Snacks Rise

PepsiCo Earnings: Beverages Dip, but Snacks Rise
But for its largest segment, North America Beverages (NAB), PepsiCo, Inc. (NYSE: PEP)  would have been able to claim a fairly impressive quarter when it released its fiscal third-quarter 2017 earnings Wednesday morning. PepsiCo’s beverage business sagged unexpectedly, causing the company to pull back on projections for full-year organic revenue growth. Yet strength in snacking division Frito-Lay North America (FLNA)... Read More